Literature DB >> 24605237

Septicemic melioidosis: a case report and literature review.

Jin-Lan Jin1, Ying-Xia Ning1.   

Abstract

This report was about a 22-year-old male patient who died from acute and severe septicemic melioidosis. He was initially misdiagnosed as having pneumonia in a local hospital in Hainan but transferred to Guangzhou Red Cross Hospital after ineffective treatment and detection of Burkholderia pseudomallei in his blood sample. Unfortunately, right diagnosis and antibiotic treatment of melioidosis had been delayed so that his condition deteriorated rapidly out of control. The victim's death highlights the importance of early diagnosis and effective antibiotic treatment of septicemic melioidosis in areas where this disease is prevalent.

Entities:  

Keywords:  Burkholderia pseudomallei; Septicemic melioidosis; carbapenem; ceftazidime

Year:  2014        PMID: 24605237      PMCID: PMC3944166          DOI: 10.3978/j.issn.2072-1439.2014.01.20

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  7 in total

1.  Why is the response rate slow in ceftazidime therapy for melioidosis?

Authors:  Savithri D Puthucheary; I-Ching Sam
Journal:  Expert Rev Anti Infect Ther       Date:  2012-01       Impact factor: 5.091

2.  Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms.

Authors:  Phannarai Pibalpakdee; Surasakdi Wongratanacheewin; Suwimol Taweechaisupapong; Pannika R Niumsup
Journal:  Int J Antimicrob Agents       Date:  2012-02-23       Impact factor: 5.283

3.  Halving of mortality of severe melioidosis by ceftazidime.

Authors:  N J White; D A Dance; W Chaowagul; Y Wattanagoon; V Wuthiekanun; N Pitakwatchara
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

4.  In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.

Authors:  M D Smith; V Wuthiekanun; A L Walsh; N J White
Journal:  J Antimicrob Chemother       Date:  1996-03       Impact factor: 5.790

Review 5.  Management of melioidosis.

Authors:  Vanaporn Wuthiekanun; Sharon J Peacock
Journal:  Expert Rev Anti Infect Ther       Date:  2006-06       Impact factor: 5.091

Review 6.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 7.  Melioidosis.

Authors:  N J White
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

  7 in total
  3 in total

1.  Melioidosis presenting as septicaemia and facial nerve palsy.

Authors:  Tessa Antony; Swathy Moorthy; Anbumani Narayanaswamy; Preetam Arthur
Journal:  BMJ Case Rep       Date:  2017-10-04

2.  Severe Sepsis with Multiorgan Failure due to Melioidosis: A Lesson to Learn.

Authors:  Dinuka S Warapitiya; Shyama Subasinghe; Rukshanie Frances de Silva; Dadallage Lalitha Piyarisi; Kushlani Jayatilleke
Journal:  Case Rep Med       Date:  2021-04-08

Review 3.  The epidemiology and clinical spectrum of melioidosis in a teaching hospital in a North-Eastern state of Malaysia: a fifteen-year review.

Authors:  AbdelRahman Zueter; Chan Yean Yean; Mahmoud Abumarzouq; Zaidah Abdul Rahman; Zakuan Z Deris; Azian Harun
Journal:  BMC Infect Dis       Date:  2016-07-16       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.